1. Home
  2. SCLX vs WKHS Comparison

SCLX vs WKHS Comparison

Compare SCLX & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

SELL

Current Price

$3.45

Market Cap

34.4M

Sector

Health Care

ML Signal

SELL

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$2.93

Market Cap

31.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
WKHS
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
34.4M
31.8M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
SCLX
WKHS
Price
$3.45
$2.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
28.5K
★ 62.6K
Earning Date
11-13-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 86.92
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
$763,173.00
Revenue This Year
$118.16
$61.80
Revenue Next Year
$186.31
$67.74
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.79
$0.53
52 Week High
$27.00
$11.80

Technical Indicators

Market Signals
Indicator
SCLX
WKHS
Relative Strength Index (RSI) 22.30 45.29
Support Level N/A $2.81
Resistance Level $5.60 $3.56
Average True Range (ATR) 0.37 0.13
MACD -0.10 0.00
Stochastic Oscillator 0.93 30.98

Price Performance

Historical Comparison
SCLX
WKHS

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: